Mirion Technologies, Inc. engages in the provision of radiation safety, science, and medicine. The company is headquartered in Atlanta, Georgia and currently employs 2,860 full-time employees. The company went IPO on 2020-06-29. The firm's segments include Nuclear & Safety and Medical. The Medical includes products and services for radiation therapy, nuclear medicine and personal dosimetry. This segment’s principal product offering is Radiation Therapy Quality Assurance, which includes solutions for calibrating and/or verifying imaging, treatment machine, patient treatment plan, and patient treatment accuracy. The Nuclear & Safety includes products and services focused on addressing critical radiation safety, measurement and analysis applications across nuclear energy, laboratories and research and other industrial markets such as defense. For Nuclear Power Plants (NPPs), it sells products and services for use at any stage of their life (construction, operation, decommissioning and dismantling).
Follow-Up Questions
Mirion Technologies Inc のCEOは誰ですか？
Mr. Thomas Logan は Mirion Technologies Inc の Chairman of the Board で、2005 から在籍しています。
MIR の株価パフォーマンスは？
MIR の現在の価格は $27.52 で、最終取引日から 1.05% decreased 変動しました。
Mirion Technologies Inc の主な事業テーマや業界は？
Mirion Technologies Inc は Electrical Equipment 業界、セクターは Information Technology に属しています。
